
Vaccine: Selangor sultan gives way to frontliners
The ruler urges the people to get their vaccine as scheduled and not be influenced by anti-vaccine groups.

The ruler urges the people to get their vaccine as scheduled and not be influenced by anti-vaccine groups.

Its single-dose regimen and normal refrigeration requirements could make the vaccine an attractive option for some.

However, some European countries say more data is needed before it is given to those over 65.

It seeks FDA approval for its single-dose vaccine for emergency use.

It will be a formidable challenge to drugmakers to manufacture to meet the rapidly-evolving coronavirus.

However, the company says it is less effective in South Africa.


The result of the study is based on blood samples taken from people who were given the vaccine.



US president and team working around the clock to get the vaccines rolled out to more states.

Otherwise, these communities risk being unprotected against a virus that does not discriminate.

German Health Minister Jens Spahn made the statement after both Pfizer and AstraZeneca announced supply issues.

Two local companies - Duopharma and Pharmaniaga - will supply the Sputnik V and Sinovac vaccines.

This will see the administering of vaccines at a location or a cluster where necessary, the minister says.

The drug maker says it found no reduction in the antibody response against the variant found in Britain.

Anti-vaxxers, conspiracy theorists continue to claim vaccine shots contain substances forbidden by Islam.

Insurance association chief explains why ‘evolving’ pandemic makes it hard to price insurance policies.

The majority of shots delivered under its Covax programme are going to poorer countries.

Islam encourages its followers to prevent diseases or seek treatment early, says Jakim research officer Fahmi Rusli.

It says the vaccines have very little risk, except for 'the frailest patients'.

New efficacy data from Brazil on this Covid-19 vaccine raises more questions than answers.


A Phase III clinical trial in Brazil finds Sinovac vaccine to be only 50.4 percent efficacious.